These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 4008982)

  • 1. Epidermolysis bullosa acquisita of the immunopathological type (dermolytic pemphigoid).
    Briggaman RA; Gammon WR; Woodley DT
    J Invest Dermatol; 1985 Jul; 85(1 Suppl):79s-84s. PubMed ID: 4008982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alterations of basement membrane zone in autoimmune subepidermal bullous diseases.
    Woźniak K; Kowalewski C
    J Dermatol Sci; 2005 Dec; 40(3):169-75. PubMed ID: 15990279
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human skin basement membrane in health and in autoimmune diseases.
    Chan LS
    Front Biosci; 1997 Jul; 2():d343-52. PubMed ID: 9232815
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The epidermal basement membrane zone--structure, ontogeny, and role in disease.
    Katz SI
    J Am Acad Dermatol; 1984 Dec; 11(6):1025-37. PubMed ID: 6512049
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens: differences in organ and species specificities and localization in chemically-separated human skin of three basement membrane antigens.
    Fine JD
    Coll Relat Res; 1985 Sep; 5(4):369-77. PubMed ID: 3902344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bullous pemphigoid and epidermolysis bullosa acquisita. Differentiation by fluorescence overlay antigen mapping.
    De Jong MC; Bruins S; Heeres K; Jonkman MF; Nieboer C; Boorsma DM; Pas HH; van der Meer JB
    Arch Dermatol; 1996 Feb; 132(2):151-7. PubMed ID: 8629822
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiating anti-lamina lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin.
    Gammon WR; Briggaman RA; Inman AO; Queen LL; Wheeler CE
    J Invest Dermatol; 1984 Feb; 82(2):139-44. PubMed ID: 6363567
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that anti-basement membrane zone antibodies in bullous eruption of systemic lupus erythematosus recognize epidermolysis bullosa acquisita autoantigen.
    Gammon WR; Woodley DT; Dole KC; Briggaman RA
    J Invest Dermatol; 1985 Jun; 84(6):472-6. PubMed ID: 3889170
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidermolysis bullosa acquisita--a pemphigoid-like disease.
    Gammon WR; Briggaman RA; Woodley DT; Heald PW; Wheeler CE
    J Am Acad Dermatol; 1984 Nov; 11(5 Pt 1):820-32. PubMed ID: 6392361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermolysis bullosa: variability of expression of cicatricial pemphigoid, bullous pemphigoid, and epidermolysis bullosa acquisita antigens in clinically uninvolved skin.
    Fine JD
    J Invest Dermatol; 1985 Jul; 85(1):47-9. PubMed ID: 3891876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of Brunsting-Perry type pemphigoid: a case showing blister formation at the lamina lucida, immune deposition beneath the lamina densa and autoantibodies against the 290-kD polypeptide along the lamina densa.
    Minato H; Ishii N; Fukuda S; Wakasa T; Wakasa K; Sogame R; Hashimoto T; Horiguchi Y
    J Dermatol; 2011 Sep; 38(9):887-92. PubMed ID: 21366683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Childhood epidermolysis bullosa acquisita. Detection in a 5-year-old girl.
    Rubenstein R; Esterly NB; Fine JD
    Arch Dermatol; 1987 Jun; 123(6):772-6. PubMed ID: 3555356
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermolysis bullosa acquisita: a clinical disorder of varied etiologies. Two cases and a review of immunologic and other reported findings.
    Wilson BD; Birnkrant AF; Beutner EH; Maize JC
    J Am Acad Dermatol; 1980 Sep; 3(3):280-91. PubMed ID: 7005274
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Double immunofluorescence microscopy: a method for localizing immune deposits in skin diseases associated with linear basement membrane zone immunofluorescence.
    Gammon WR; Robinson T; Briggaman RA; Wheeler CE
    J Invest Dermatol; 1982 Nov; 79(5):312-7. PubMed ID: 6752293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A mouse monoclonal antibody against a newly discovered basement membrane component, the epidermolysis bullosa acquisita antigen.
    Paller AS; Queen LL; Woodley DT; Gammon WR; O'Keefe EJ; Briggaman RA
    J Invest Dermatol; 1985 Mar; 84(3):215-7. PubMed ID: 3882847
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired bullous diseases of childhood: re-evaluation of diagnosis by indirect immunofluorescence examination on 1 M NaCl split skin and immunoblotting.
    Kirtschig G; Wojnarowska F; Marsden RA; Edwards S; Bhogal B; Black MM
    Br J Dermatol; 1994 May; 130(5):610-6. PubMed ID: 8204469
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in complement-dependent chemotactic activity generated by bullous pemphigoid and epidermolysis bullosa acquisita immune complexes: demonstration by leukocytic attachment and organ culture methods.
    Gammon WR; Inman AO; Wheeler CE
    J Invest Dermatol; 1984 Jul; 83(1):57-61. PubMed ID: 6376640
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Direct immunofluorescence microscopy of 1 mol/L sodium chloride-treated patient skin.
    Domloge-Hultsch N; Bisalbutra P; Gammon WR; Yancey KB
    J Am Acad Dermatol; 1991 Jun; 24(6 Pt 1):946-51. PubMed ID: 1869682
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Basement membrane reactivity of antisera to type IV collagen and sera from patients with bullous pemphigoid and epidermolysis bullosa acquisita.
    Peng TK; Nisengard RJ; Levine MJ; Beutner EH
    Proc Natl Sci Counc Repub China B; 1984 Jul; 8(3):268-73. PubMed ID: 6400590
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermolysis bullosa acquisita with combined features of bullous pemphigoid and cicatricial pemphigoid.
    Wieme N; Lambert J; Moerman M; Geerts ML; Temmerman L; Naeyaert JM
    Dermatology; 1999; 198(3):310-3. PubMed ID: 10393462
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.